Delivery Order SPE2DB20D1109-SPE2DB25FP44G
- Not listed
- The Defense Logistics Agency awarded a $34,787.81 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Biktarvy 50-200-25 mg tablets (30-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 25, 2025. The contract is performed from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $10,861.62 to AmerisourceBergen Drug Corp for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This competitively awarded, firm fixed-price delivery order has an ultimate completion date of July 25, 2025, and represents a non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will fulfill this pharmaceutical supply requirement from its corporate office location....
- The Defense Logistics Agency awarded a delivery order valued at $39,564.88 to AmerisourceBergen Drug Corp for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30s. This is a firm fixed price, competitively awarded contract with an ultimate completion date of July 24, 2025. The award carries no set-aside designation, indicating it was competed among eligible vendors. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $5,907.98 and an ultimate completion date of July 22, 2025. The contract carries no set-aside designation, indicating it was competitively awarded. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at twenty thousand one hundred forty-six dollars and eighty-five cents ($20,146.85) to Amerisourcebergen Drug Corporation for the supply of Biktarvy 50-200-25 mg tablets. Performance will take place in Conshohocken, Pennsylvania under the terms of the contract from July 7, 2023 through July 10, 2023. Biktarvy is used to treat human immunodeficiency virus (HIV)-1 infection in adults and is a key...
- The Defense Logistics Agency awarded a $37,328 delivery order to Amerisourcebergen Drug Corporation for Biktarvy tablets. Under this firm fixed price contract, Amerisourcebergen will provide 50-200 milligram doses of the HIV treatment medication in bottles of 30 tablets. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period from September 13th to September 14th, 2023. No subcontractors or set aside designations were specified. This...
- The Defense Logistics Agency awarded a $45,868 delivery order to Amerisourcebergen Drug Corporation to supply Biktarvy tablets. Under the terms of the firm fixed price contract, Amerisourcebergen will deliver 50-200 milligram doses of the HIV treatment medication in bottles of 30 tablets each. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period of three days from September 29th through October 2nd, 2023. No set aside provisions or...
- The Defense Logistics Agency awarded a $48,283 delivery order to Amerisourcebergen Drug Corporation to supply Biktarvy tablets. Under this firm fixed price contract, Amerisourcebergen will deliver 50-200 milligram doses of the HIV treatment medication in bottles of 30 tablets each. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period of three days from September 8 through September 11, 2023. No subcontractors or set aside designations were...
- The Defense Logistics Agency awarded a delivery order valued at $1,548.16 to AmerisourceBergen Drug Corp for Biktarvy 50-200-25 mg tablets (30-count unit dose packaging). The contract, issued on July 23, 2025, with an ultimate completion date of July 24, 2025, represents a firm fixed-price delivery against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. This delivery order is not set-aside and was competitively awarded. AmerisourceBergen, headquartered...
- Amerisourcebergen Drug Corporation, operating as a division of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order valued at $137,119.51 to supply Biktarvy tablets to the Defense Logistics Agency Troop Support Medical (DLA). Performance will take place in Conshohocken, Pennsylvania over a period of one day, from August 10th to August 11th, 2023. Biktarvy is a complete HIV treatment regimen containing bictegravir, emtricitabine, and tenofovir alafenamide. The...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB25FP44GDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $29,406.51 to AmerisourceBergen Drug Corp for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This firm fixed-price, competitively awarded contract has an ultimate completion date of July 24, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Biktarvy is an antiretroviral medication used in HIV treatment, reflecting the critical pharmaceutical supply needs of the federal healthcare system, particularly for military and veteran populations served through DLA's medical supply chain. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999.00 prime vendor agreement valued through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies globally to support military healthcare programs. The non-set-aside award demonstrates AmerisourceBergen's continued capability to compete for federal medical procurement requirements and reflects its significant role as a major pharmaceutical distributor supporting Defense Health Agency operations and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $29.4k | 7/23/25 |